4//SEC Filing
Benton Andrew 4
Accession 0001493152-22-017872
CIK 0001716947other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:38 PM ET
Size
5.6 KB
Accession
0001493152-22-017872
Insider Transaction Report
Form 4
Benton Andrew
Director
Transactions
- Award
Stock Option
2022-06-23+15,000→ 100,850 totalExercise: $0.42Exp: 2032-06-23→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]On June 23, 2022, Mr. Benton was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.
Documents
Issuer
Ensysce Biosciences, Inc.
CIK 0001716947
Entity typeother
Related Parties
1- filerCIK 0001867975
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:38 PM ET
- Size
- 5.6 KB